3. Indications and contraindications
▶
Hysterectomy remains the gold standard treatment for a great number of gynaecological conditions. It should be performed only when conventional treatments have failed. The patient’s age and desire for pregnancy are essential factors that determine the treatment. The benefit-risk ratio should be assessed before any intervention, especially in case of benign pathologies.
Indications (Lefebvre et al., 2002)
Benign conditions:
a) Leiomyomas: in cases of fibromas with invalidating symptoms, hysterectomy is the treatment modality once medical treatments have failed.
b) Menometrorrhagia: once a malignant endometrial or cervical pathology has been ruled out, medical treatment is first-line together with hysterectomy. In case of failure, hysterectomy may be carried out, especially in case of secondary anemia.
c) Genital prolapse: in case of prolapse of uterus, hysterectomy may be associated with certain surgical procedures. For instance, in case of sacral promontofixation, hysterectomy helps to reconstruct the vagina and its attachments through reconstruction of the pericervical ring along with adequate traction on the prosthetic material.
d) Endometriosis/adenomyosis: hysterectomy may be the last option in case of major pelvic pain syndrome resistant to treatment and when the patient has no desire for pregnancy.
e) Pelvic pain syndrome: the benefit of hysterectomy is not proven; as a result, it should be performed only in cases of alternative treatment failure and after preliminary consultations with health care professionals (psychologists, physical therapists, and gynecologists). Hysterectomy may be beneficial when pain originates from dysmenorrhea or is associated with major pelvic pain.
Pre-invasive pathologies:
- endometrial hyperplasia with atypia;
- cervical carcinoma in situ is not an indication for hysterectomy. However, it may be performed when conization is carried out in diseased portions of the cervix or when the patient desires natural childbirth.
- cervical adenocarcinoma in situ: caution must be taken that there is no invasive lesion associated.
Malignant conditions:
- endometrial cancer and cervical cancer: therapeutic role and staging;
- ovarian cancer and tubal carcinoma: the role of laparoscopy is still debated, apart from staging.
Indications and contraindications to the laparoscopic approach:
Apart from morcellation in cases of malignant pathologies and anesthesia-related contraindications, there is no such contraindication to laparoscopic hysterectomy. Studies undertaken by Wattiez et al. (Wattiez A, Soriano D, Cohen SB, Nervo P, Canis M, Botchorishvili R et al. The learning curve of total laparoscopic hysterectomy: comparative analysis of 1647 cases. J Am Assoc Gynecol Laparosc 2002;9:339-45) have shown that with adequate training, laparoscopic hysterectomy is a safe, effective, and reproducible technique. About 30 laparoscopic hysterectomies are estimated to obtain complication rates and operative times similar to the ones of other approaches. Even a bulky uterus becomes accessible with this approach once a few protocols have been implemented (shifting of ports and use of uterine manipulators) (Wattiez A, Soriano D, Fiaccavento A, Canis M, Botchorishvili R, Pouly J et al. Total laparoscopic hysterectomy for very enlarged uteri. J Am Assoc Gynecol Laparosc 2002;9:125-30).
Nowadays, the main limiting factor is to laparoscopic hysterectomy is assuredly the lack of experience of surgeons.
Nevertheless, following the recommendations of the Cochrane Database Systematic Review of January 2005, vaginal hysterectomy should be performed whenever possible. When the vaginal route fails, the laparoscopic approach precludes laparotomy (Johnson et al., 2005). |